Transcriptomics

Dataset Information

0

Lysosome-dependent LXR and PPARdelta Activation upon Efferocytosis in Human Macrophages


ABSTRACT: Efferocytosis is critical for tissue homeostasis, as its deregulation is associated with several autoimmune pathologies. While engulfing apoptotic cells, phagocytes activate transcription factors, such as peroxisome proliferator-activated receptors (PPAR) or liver X receptors (LXR) that orchestrate metabolic, phagocytic, and inflammatory responses towards the ingested material. Coordination of these transcription factors in efferocytotic human macrophages (MF) is not fully understood. In this study, we evaluated the transcriptional profile of MF following the uptake of apoptotic Jurkat T cells using RNA-seq analysis. Results indicated upregulation of PPAR and LXR pathways but downregulation of sterol regulatory element-binding proteins (SREBP) target genes. Pharmacological inhibition and RNA interference pointed to LXR and PPARdelta as relevant transcriptional regulators, while PPARdelta did not substantially contribute to gene regulation. Mechanistically, lysosomal digestion and lysosomal acid lipase (LIPA) were required for PPAR and LXR activation, while PPARdelta activation also demanded an active lysosomal phospholipase A2 (PLA2G15). Pharmacological interference with LXR signaling attenuated ABCA1-dependent cholesterol efflux from efferocytotic MF, but suppression of inflammatory responses following efferocytosis occurred independently of LXR and PPARdelta. These data provide mechanistic details on LXR and PPARdelta activation in efferocytotic human MF.

ORGANISM(S): Homo sapiens

PROVIDER: GSE169160 | GEO | 2021/05/26

REPOSITORIES: GEO

Similar Datasets

2018-11-30 | GSE119273 | GEO
| PRJNA715460 | ENA
2024-01-23 | GSE253579 | GEO
2010-06-21 | E-GEOD-17890 | biostudies-arrayexpress
2009-10-18 | GSE17890 | GEO
2021-11-22 | ST001997 | MetabolomicsWorkbench
2021-11-22 | ST001999 | MetabolomicsWorkbench
2021-11-22 | ST001998 | MetabolomicsWorkbench
2021-11-22 | ST001996 | MetabolomicsWorkbench
2023-12-12 | PXD038390 | Pride